Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coenzyme A (CoA)-dependent enzymes constitute a vast and essential functional class of proteins, representing approximately 4% of all cellular enzymes, that utilize CoA or its thioester derivatives as substrates, products, or cofactors [1.2.1, 1.3.1]. These enzymes are central to primary metabolism, facilitating critical pathways such as the tricarboxylic acid (TCA) cycle, fatty acid biosynthesis and beta-oxidation, and the synthesis of cholesterol, ketone bodies, and heme [1.1.2, 1.3.1]. Beyond energy production, they play vital roles in signal transduction and gene expression through the post-translational modification of proteins via acetylation and the synthesis of neurotransmitters like acetylcholine [1.1.1, 1.3.2]. Due to their fundamental roles in metabolic homeostasis, many CoA-dependent enzymes are major therapeutic targets; for instance, HMG-CoA reductase is the target of statins for treating hypercholesterolemia, while others like acetyl-CoA carboxylase and ATP-citrate lyase are targeted for metabolic diseases and cancer [1.4.2, 1.4.3]. Dysregulation or genetic mutations in these enzymes are linked to a wide range of pathologies, including cardiovascular disease, diabetes, oncology, and rare neurodegenerative disorders such as pantothenate kinase-associated neurodegeneration (PKAN) [1.1.3, 1.1.4]. Pharmacological intervention typically involves small-molecule inhibitors that compete with CoA or its acyl-thioesters for binding sites, thereby modulating lipid profiles or cellular energy balance [1.2.1, 1.4.3]. In addition to human health, these enzymes are explored as targets for novel antimicrobials, as bacterial fatty acid synthesis and CoA biosynthesis pathways often differ significantly from their human counterparts [1.2.2, 1.2.5].
Inhibition of specific enzymes within the class, such as HMG-CoA reductase, ATP-citrate lyase, or acetyl-CoA carboxylase, to modulate lipid metabolism and cellular energy levels [1.4.2, 1.4.3].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coenzyme A-dependent enzyme (CoA-dependent enzyme).